ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Metabolomics reveals the potential metabolic mechanism of infliximab against DSS-induced acute and chronic ulcerative colitis.

Guoqiang Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.